204
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

, , , &
Pages 347-353 | Published online: 08 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh & Farideh Javid. (2023) Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects. Expert Review of Clinical Pharmacology 16:1, pages 49-59.
Read now

Articles from other publishers (4)

AshokK Das, Pramod Gandhi, Banshi Saboo, Sanjay Reddy, Rajeev Chawla, AbdulHamid Zargar, Rajiv Kovil, Manoj Chawla, SK Sharma, Sunil Gupta, BM Makkar, Vinod Mittal, Soumik Goswami, SR Arvind, Shalini Jaggi, Sarita Bajaj & Sambit Das. (2021) Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion. Journal of Family Medicine and Primary Care 10:12, pages 4398.
Crossref
Sujoy Ghosh, Mangesh Tiwaskar, Rajiv Chawla, Shalini Jaggi, Arthur Asirvatham & Vijay Panikar. (2020) Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2). Diabetes Therapy 11:10, pages 2257-2268.
Crossref
Shrikrishna V. Acharya. (2020) Is Teneligliptin Safe in Patients with Diabetes Mellitus Mainly with Reference to QT Prolongation. Journal of Evolution of Medical and Dental Sciences 9:31, pages 2171-2175.
Crossref
Ahsan Sajjad. (2017) Comparison of Efficacy and Safety of Hydroxychloroquine and Teneligliptin in Type 2 Diabetes Patients who are Inadequately Controlled with Glimepiride, Metformin and Insulin therapy: A Randomized Controlled Trial with Parallel Group Design. Annals of Clinical Endocrinology and Metabolism 2:1, pages 033-040.
Crossref